+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colorectal Cancer Drug"

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Metastatic Colorectal Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Metastatic Colorectal Cancer - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 154 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Colorectal Cancer (CRC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Colorectal Cancer (CRC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Colorectal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Colorectal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 172 Pages
  • Global
From
Colorectal Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Colorectal Cancer Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 146 Pages
  • Global
From
Colorectal Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Colorectal Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • June 2022
  • 117 Pages
  • Global
From
Colorectal Cancer Diagnostics Market Forecast to 2028 - Global Analysis By Modality and End User - Product Thumbnail Image

Colorectal Cancer Diagnostics Market Forecast to 2028 - Global Analysis By Modality and End User

  • Report
  • May 2023
  • 213 Pages
  • Global
From
Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis

  • Report
  • December 2023
  • 146 Pages
  • Global
From
Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • June 2022
  • 53 Pages
  • Global
From
Colorectal Cancer: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Colorectal Cancer: Global Drug Forecast and Market Analysis to 2028

  • Report
  • April 2020
  • 153 Pages
  • Global
From
Europe Colorectal Cancer Screening Market Size, Share & Industry Trends Analysis Report By Type (Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), By End-user, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Colorectal Cancer Screening Market Size, Share & Industry Trends Analysis Report By Type (Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), By End-user, By Country and Growth Forecast, 2023 - 2030

  • Report
  • August 2023
  • 133 Pages
  • Europe
From
Microsatellite Stable Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Metastatic Colorectal Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Metastatic Colorectal Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 88 Pages
  • Global
From
Colorectal Cancer Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Colorectal Cancer Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 135 Pages
  • Global
From
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1588 Pages
  • Global
From
Colorectal Cancer Diagnosis and Therapeutic Updates - Product Thumbnail Image

Colorectal Cancer Diagnosis and Therapeutic Updates

  • Book
  • June 2022
Colorectal Cancer Treatment Resistance. Mechanisms, Insights, Advances, and Solutions - Product Thumbnail Image

Colorectal Cancer Treatment Resistance. Mechanisms, Insights, Advances, and Solutions

  • Book
  • October 2024
Loading Indicator

The Colorectal Cancer Drug market is composed of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and reduce the risk of recurrence. Commonly used drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is the most common treatment for colon cancer, and is used to kill cancer cells. Targeted therapy is used to target specific molecules in cancer cells, while immunotherapy is used to boost the body’s immune system to fight cancer. Hormone therapy is used to reduce the production of hormones that can cause cancer cells to grow. Companies in the Colorectal Cancer Drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, and Roche. Show Less Read more